Clinical Trial Update: Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation [Phase 1, Phase 2]

View source ↗

Summary

Mallinckrodt-sponsored Phase 1/2 trial evaluating inhaled nitric oxide for neonates with elevated A-a DO2 gradients not requiring mechanical ventilation was ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxemia
• Respiratory Acidosis

Drugs mentioned

• INOmax (nitric oxide)

Snippet

Sponsor: Mallinckrodt | Conditions: Lung Disease, Hypoxemia | Phase 1, Phase 2 | Status: TERMINATED